Innovative Web-based Service Platform Called Adult Wellbeing CheckUp (AWC) to Assess Older Adults Wellbeing, Obtain Evidence-based Recommendations, and Receive Support to Take Action.

March 19, 2026 updated by: BellAge Inc.

Adult Wellbeing CheckUp (AWC)

The goal of this clinical trial is to learn whether a web-based program called the Adult Wellbeing CheckUp (AWC) can help older adults improve their wellbeing and take actions to support healthy aging. The study will include adults aged 60 years and older, including both older adults and people who care for someone living with Alzheimer's disease or related dementias.

The main questions this study aims to answer are:

  1. Does using the Adult Wellbeing CheckUp increase participants' ability to manage their health and wellbeing, measured by the Patient Activation Measure (PAM-13)?
  2. Do participants who use the Adult Wellbeing CheckUp take more actions to improve their wellbeing compared with those who do not use the program?

Researchers will compare participants who use the AWC platform with participants who receive general healthy aging information to see whether the AWC program leads to greater improvements in wellbeing and health engagement.

The AWC platform is an online tool that helps older adults review their wellbeing across several areas of life, such as physical health, mental health, social connections, and daily habits. After completing an online assessment, the platform provides personal action plans and specific recommendations to help participants improve areas where their wellbeing scores are low.

About 496 participants aged 60 and older will take part in this study. This group will include both older adults and care partners for people living with Alzheimer's disease or related dementias. Participants will take part in the study for about 24 weeks (6 months).

Participants will be randomly assigned (by chance) to one of two groups:

  1. Intervention group: Participants will create an account and use the Adult Wellbeing CheckUp platform for 24 weeks. They will complete a wellbeing assessment and receive personal action plans and specific recommendations. They will also receive weekly encouragement messages and personalized check-ins by email or text.
  2. Comparison group: Participants will complete the same baseline assessment but will not have access to the AWC platform during the study. Instead, they will receive weekly general healthy aging information by email.

All participants will complete surveys at the start of the study, at 12 weeks, and at 24 weeks. These surveys will measure health engagement, wellbeing, and actions taken to improve wellbeing. After the study ends, participants in the comparison group may be offered access to the platform in a future time.

Researchers will use the results of this study to learn whether the Adult Wellbeing CheckUp can help older adults take meaningful steps to improve their health and wellbeing.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

496

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • New York
      • Sunnyside, New York, United States, 11104
        • BellAge Inc.dba BetterAge
        • Contact:
        • Principal Investigator:
          • James Firman, MBA, Ed.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • older adults aged 60 years or older,
  • able to speak and write in English,
  • a PHQ-2 depression screening score of less than 3,
  • has ability to access the internet,
  • can demonstrate literacy using online platforms, and
  • has access to an active email account that they can use to receive study-related communications.

Exclusion Criteria:

  • less than 60 years of age
  • not able to speak and write in English
  • a PHQ-2 depression screening score of 3 or greater
  • not able to access the internet, and
  • not able to demonstrate literacy using online platforms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adult Wellbeing CheckUp (AWC) Intervention Group
Participants in this arm will use the Adult Wellbeing CheckUp (AWC), a web-based wellbeing assessment and recommendation platform, for 24 weeks. After completing the baseline assessment, participants will answer domain-specific follow-up questions for wellbeing areas with low scores or areas they want to improve. Based on these responses, the platform will generate evidence-based recommendations and actionable plans. Participants will also receive ongoing encouragement messages and check-ins by email or text during the 24-week study period.
The Adult Wellbeing CheckUp (AWC) is a web-based wellbeing assessment and recommendation platform designed for older adults and care partners. Participants complete an online assessment of multiple wellbeing domains. The platform uses a rules-based algorithm to generate evidence-based guidance and actionable plans for domains with low scores or areas participants choose to improve. Participants in the intervention arm receive ongoing encouragement messages and check-ins via email or text over the 24-week study period.
Active Comparator: General Healthy Aging Information Control Group
Participants in this arm will complete the same baseline assessment as the intervention group but will not receive access to the Adult Wellbeing CheckUp platform, personal action plans or recommendations, or digital support during the 24-week study period. Instead, they will receive weekly non-personalized general healthy aging informational messages by email.
Participants receive weekly non-personalized informational messages about general healthy aging topics delivered by email during the 24-week study period. These messages provide general education but do not include personal recommendations, interactive features, or access to the Adult Wellbeing CheckUp platform.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Patient Activation Measure (PAM-13) Score
Time Frame: Baseline, Week 12, and Week 24
Patient activation measured using the 13-item Patient Activation Measure (PAM-13), a validated survey that assesses participants' knowledge, skills, and confidence for managing their health and wellbeing. Scores range from 0 to 100, with higher scores indicating greater activation. The primary analysis will compare change in PAM-13 scores between intervention and control groups.
Baseline, Week 12, and Week 24

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Self-Reported Actions Taken
Time Frame: Baseline and Week 24
Participant-reported actions taken to improve wellbeing in prioritized domains based on recommendations provided during the study. Responses are used to assess follow-through on recommended wellbeing actions.
Baseline and Week 24
Change in Adult Wellbeing Assessment Score
Time Frame: Baseline and Week 24
Overall wellbeing measured using the Adult Wellbeing Assessment, a 13-item self-report questionnaire designed for older adults. The measure assesses multiple domains of wellbeing, including physical health, mental and emotional wellbeing, social connection, sense of purpose, and daily functioning. Responses are scored to produce an overall wellbeing score, with higher scores indicating better overall wellbeing.
Baseline and Week 24
Change in Patient Health Questionnaire-4 (PHQ-4) Score
Time Frame: Baseline and Week 24
Mental health symptoms measured using the Patient Health Questionnaire-4 (PHQ-4), a validated 4-item screening tool assessing anxiety and depression symptoms. Scores range from 0 to 12, with higher scores indicating greater symptom severity.
Baseline and Week 24
Change in Rapid Assessment of Physical Activity (RAPA) Score
Time Frame: Baseline and Week 24
Physical activity level measured using the Rapid Assessment of Physical Activity (RAPA). Aerobic activity (RAPA-1) is scored based on the highest numbered activity level endorsed (1-7), classifying participants from sedentary to active. Strength and flexibility activities (RAPA-2) are recorded separately and categorized as none (0), strength only (1), flexibility only (2), or both strength and flexibility activities (3).
Baseline and Week 24
Change in UCLA Loneliness Scale-3 Score
Time Frame: Baseline and Week 24
Emotional loneliness measured using the UCLA Loneliness Scale-3, a validated 3-item self-report scale assessing perceived loneliness and social isolation. Scores range from 3 to 9, with higher scores indicating greater loneliness.
Baseline and Week 24
Change in Lubben Social Network Scale (LSNS-6) Score
Time Frame: Baseline and Week 24
Social isolation measured using the Lubben Social Network Scale (LSNS-6), a validated 6-item measure assessing perceived social support from family and friends. Scores range from 0 to 30, with higher scores indicating larger and more supportive social networks.
Baseline and Week 24
Change in Duke Sense of Belonging Short Form Score
Time Frame: Baseline and Week 24
Sense of belonging and social connectedness measured using two items adapted from the Duke Social Support/Sense of Belonging questionnaire assessing frequency of contact and time spent with friends or family. The first item assesses frequency of contact with friends or family (in person, by phone, or by video) and is scored on a 5-point scale from 1 (rarely or never) to 5 (daily). The second item assesses the number of times participants spend time with someone who does not live with them in a typical week and is scored on a 4-point scale from 1 (none) to 4 (five or more times). Item scores are summed to produce a total score ranging from 2 to 9, with higher scores indicating greater social connectedness and sense of belonging.
Baseline and Week 24
Change in PROMIS Sleep Disturbance Short Form Score
Time Frame: Baseline and Week 24
Sleep disturbance measured using the PROMIS Sleep Disturbance Short Form (8a), an 8-item validated self-report questionnaire assessing perceived sleep quality, sleep depth, and difficulty falling or staying asleep over the past seven days. Each item is rated on a 5-point response scale. Responses are summed to produce a raw score ranging from 8 to 40. Higher T-scores indicate greater sleep disturbance.
Baseline and Week 24
Change in Topic-Level Impact Ratings
Time Frame: Week 12 and Week 24
Change in perceived impact of actions taken within prioritized wellbeing domains measured using a single-item question. Participants rate the impact of actions taken in specific domains using a numeric rating scale from 0 to 10, where 0 indicates no impact and 10 indicates very high positive impact on wellbeing. Higher scores indicate greater perceived positive impact of actions taken within the selected wellbeing domain.
Week 12 and Week 24
Change in Global Impact of Actions Score
Time Frame: Week 12 and Week 24
Change in perceived overall impact of actions taken on wellbeing measured using a single-item question. Participants rate the overall impact of actions taken on their wellbeing using a numeric rating scale from 0 to 10, where 0 indicates no impact and 10 indicates very high positive impact on overall wellbeing. Higher scores indicate greater perceived overall benefit from actions taken.
Week 12 and Week 24
Reported Barriers to Taking Action
Time Frame: Week 12 and Week 24
Participant-reported barriers that may limit engagement with recommended wellbeing actions. Barriers are assessed using a survey question allowing participants to select one or more applicable options from a predefined list (e.g., time constraints, lack of resources, lack of motivation, or other challenges).
Week 12 and Week 24
Change in Zarit Burden Interview (ZBI-12) Score
Time Frame: Baseline and Week 24
Change in caregiver burden among care partner participants measured using the 12-item Zarit Burden Interview (ZBI-12). Each item is rated on a 5-point Likert scale from 0 (never) to 4 (nearly always). Total scores range from 0 to 48, with higher scores indicating greater caregiver burden.
Baseline and Week 24

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
System Usability Scale (SUS) Score
Time Frame: Week 24
Usability of the Adult Wellbeing Checkup (AWC) platform assessed among intervention participants using the System Usability Scale (SUS), a validated 10-item questionnaire evaluating perceived ease of use and usability of digital systems. Each item is rated on a 5-point Likert scale from strongly disagree to strongly agree. Responses are converted to a total score ranging from 0 to 100, with higher scores indicating greater perceived system usability.
Week 24
Perceptions of Technology Usage
Time Frame: Week 24
The first question would address whether the participant found the platform helpful and useful, and the second question would address whether the participant would desire to use the platform. Both questions are rated on a Likert scale (e.g., 1 = strongly disagree to 5 = strongly agree). Higher scores indicate greater perceived usefulness.
Week 24

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Fauth E,Hess K,Piercy K,Norton M,Corcoran C,Rabins P,Lyketsos C,Tschanz J

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 6, 2026

Primary Completion (Estimated)

April 6, 2027

Study Completion (Estimated)

April 6, 2027

Study Registration Dates

First Submitted

March 19, 2026

First Submitted That Met QC Criteria

March 19, 2026

First Posted (Actual)

March 23, 2026

Study Record Updates

Last Update Posted (Actual)

March 23, 2026

Last Update Submitted That Met QC Criteria

March 19, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

The research team has not yet determined whether individual participant data will be shared with external researchers. Any future sharing of de-identified data will be evaluated after study completion in accordance with participant consent, sponsor policies, and applicable privacy and data protection regulations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Control Group

Subscribe